16.04.2013 • News

Solvay to Build Large-scale Alkoxylation Facility in Singapore

Solvay announces today that it will build a large-scale alkoxylation facility in Singapore which is expected to start operations by 2015.

The facility will be connected to Shell's new High Purity Ethylene Oxide (HPEO) unit located in the world-class, integrated petrochemical hub of Jurong Island. Through the alkoxylation process key monomers are produced that serve downstream surfactant development and manufacturing.

The investment comes after Solvay last week announced that it would build a specialty surfactant plant near Berlin, serving the Central and Eastern European markets.

Solvay Novecare is already Asia's largest specialty surfactant manufacturer with 11 production sites and two R&D centers in Singapore and Shanghai. The new plant will produce specialty alkoxylate surfactants which deliver targeted cleansing, dispersing, defoaming and emulsifying performance attributes in formulations.

The "on pipe" facility will be supplied by an ethylene oxide (EO) pipe from Shell to feed the alkoxylation activities, highlighting both Solvay Novecare's long-term commitment to sustainable production and growing demand from its end markets.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read